Asset Management System 1st Surveillance Audit
As a result of the ISO 55001:2014 Asset Management System Certification Audit carried out by ICAS (International Conformity Assessment Service Inc., subsidiary of Turkish Standards Institute TSE) officials in December 2021, PharmaVision was accorded an Asset Management System Certificate encompassing all its assets (physical and non-physical) used in pharmaceuticals manufacturing. PharmaVision had thus become the first company in the Turkish pharmaceutical industry to obtain this certificate.
As a consequence of the 1st Surveillance Audit carried out on November 3, 2022, by 4 auditors from ICAS accompanied by 2 UAF (United Accreditation Foundation) auditors observing them, it was decided to renew PharmaVision’s ISO 55001 Asset Management System Certificate.
We would like to take this opportunity to thank all our colleagues who contributed, made efforts and supported the establishment and improvement of this system and commit to continuously improve our Asset Management System with the participation of all our employees.
* ICAS is accredited by UAF (United Accreditation Foundation).
|